SEND US YOUR QUESTIONS FOR THE EXPERTS HERE
(During the podcast, you can interact with the moderator through our TMA Facebook page, or using the chat function in GoToWebinar)
About our Guest Speakers
Carlos Pardo-Villamizar, MD
Dr. Pardo is a Professor of Neurology (Division of Neuroimmunology and Neuroinfectious Disorders) and Pathology (Neuropathology) at Johns Hopkins University School of Medicine in Baltimore, Maryland. He is the principal investigator of the Neuroimmunopathology Laboratory, member of the HIV Neurosciences Research Group and clinical neurologist at the Multiple Sclerosis and Transverse Myelitis Centers at Johns Hopkins Hospital. His clinical specialization is on neuroimmunological and Infectious disorders of the nervous system, with particular focus on multiple sclerosis, transverse myelitis, neurosarcoidosis, and neurological complications of autoimmune disorders.
Bardia Nourbakhsh, MAS, MD
Bardia Nourbakhsh, MD, is an assistant professor of neurology at Johns Hopkins University School of Medicine. Dr. Nourbakhsh is board-certified in neurology by the American Board of Psychiatry and Neurology. He practices out of The Johns Hopkins Hospital in Baltimore, Maryland and is affiliated with Sibley Memorial Hospital in Washington, D.C.
Dr. Nourbakhsh has an expertise in multiple sclerosis (MS) and neuroimmunology.
Dr. Nourbakhsh earned his medical degree from Tehran University School of Medical Sciences and completed a residency in neurology at University of Texas Southwestern Medical Center. He studied epidemiology, study design and biostatistics, obtaining a Masters of Advanced Studies degree in clinical research from the University of California, San Francisco School of Medicine, where he also completed a fellowship in MS and neuroimmunology.
In 2014, Dr. Nourbakhsh earned the American Brain Foundation Clinical Research Training Fellowship in MS, the National Multiple Sclerosis Society Sylvia Lawry Clinical Research Fellowship, the Fred Baskin Young Investigator Award and the Teva Neuroscience Award for Academic Excellence.
Dr. Nourbakhsh’s research training focused on the design and execution of clinical trials and use of biomarkers in MS. His current research interests include the comparative effectiveness studies of symptomatic and disease-modifying therapies in MS, as well as identifying new pathophysiologic mechanisms and therapeutic targets for MS-related fatigue. Dr. Nourbakhsh is the principal investigator of a two-center, randomized, double-blind crossover clinical trial funded by the Patient-Centered Outcomes Research Institute, which focuses on commonly used fatigue medications for MS. He has contributed to numerous publications, journal articles, abstracts and posters, and lectures. He is an ad hoc reviewer for Annals of Neurology, Journal of Neurological Sciences, Neurology: Neuroimmunology and Neuroinflammation, JAMA Neurology, Frontiers Molecular Biosciences and other journals.
SRNA Ask the Expert Podcast Series sponsored in part by
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal is to deliver medical breakthroughs where none currently exist, and they are committed to ensuring that patient perspective and community engagement is always at the forefront of their work.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit https://www.gene.com.
Viela Bio is dedicated to the development and commercialization of novel, life-changing medicines for patients with a wide range of autoimmune and severe inflammatory diseases. Their team is comprised of passionate, talented, world-class leaders with diverse experience in the autoimmune disease space, and their research focuses on well-established critical biological pathways shared across multiple indications.
* The Executive Committee of SRNA with the medical and scientific council determines the content and topics of the podcasts. Sponsors are not able to influence the education program.
